Goffredo Donato, Rigamonti Dorotea, Tartari Marzia, De Micheli Alberto, Verderio Claudia, Matteoli Michela, Zuccato Chiara, Cattaneo Elena
Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases, University of Milan, Milano, Italy.
J Biol Chem. 2002 Oct 18;277(42):39594-8. doi: 10.1074/jbc.C200353200. Epub 2002 Aug 27.
Huntington's disease (HD) is caused by a polyglutamine expansion in the amino-terminal region of huntingtin. Mutant huntingtin is proteolytically cleaved by caspases, generating amino-terminal aggregates that are toxic for cells. The addition of calpains to total brain homogenates also leads to cleavage of wild-type huntingtin, indicating that proteolysis of mutant and wild-type huntingtin may play a role in HD. Here we report that endogenous wild-type huntingtin is promptly cleaved by calpains in primary neurons. Exposure of primary neurons to glutamate or 3-nitropropionic acid increases intracellular calcium concentration, leading to loss of intact full-length wild-type huntingtin. This cleavage could be prevented by calcium chelators and calpain inhibitors. Degradation of wild-type huntingtin by calcium-dependent proteases thus occurs in HD neurons, leading to loss of wild-type huntingtin neuroprotective activity.
亨廷顿舞蹈症(HD)是由亨廷顿蛋白氨基末端区域的多聚谷氨酰胺扩展引起的。突变型亨廷顿蛋白被半胱天冬酶进行蛋白水解切割,产生对细胞有毒性的氨基末端聚集体。向全脑匀浆中添加钙蛋白酶也会导致野生型亨廷顿蛋白的切割,这表明突变型和野生型亨廷顿蛋白的蛋白水解可能在亨廷顿舞蹈症中起作用。在此我们报告,内源性野生型亨廷顿蛋白在原代神经元中会被钙蛋白酶迅速切割。原代神经元暴露于谷氨酸或3 - 硝基丙酸会增加细胞内钙浓度,导致完整全长野生型亨廷顿蛋白的缺失。这种切割可被钙螯合剂和钙蛋白酶抑制剂阻止。因此,在亨廷顿舞蹈症神经元中会发生由钙依赖性蛋白酶介导野生型亨廷顿蛋白的降解,导致野生型亨廷顿蛋白神经保护活性丧失。